Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.86 (market cap $6.04B), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $60.62 (market cap $3.39B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and SP Funds S&P 500 Sharia Industry Exclusions ETF is more actively traded (349,184 versus 14,805,993). Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and SP Funds S&P 500 Sharia Industry Exclusions ETF for 64 Days on average.
| IOVA | SPUS | |
|---|---|---|
Market Cap | $6.04B | $3.39B |
Volume | 14,805,993 | 349,184 |
Sector | Health | Broad Market / Factor |
52-Week High | $14.82 | $61.15 |
52-Week Low | $1.81 | $46.65 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPUS (SP Funds S&P 500 Sharia Industry Exclusions ETF) trades at $61.07, down 0.13% with a bullish technical signal from moving averages but bearish oscillators. The ETF shows consistent dividend payments of $0.03 monthly through mid-2026. Short interest surged 174.5% to 257,142 shares in September 2026, indicating growing bearish sentiment among some investors despite the overall technical strength.
The ETF's outlook remains mixed with strong technical momentum countered by elevated short interest and overbought RSI levels. Investment opportunity lies in Sharia-compliant S&P 500 exposure, while risks include concentrated short positioning and potential mean reversion from current technical extremes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
